Stock Market News for August 20, 2026

Big Tech & China Internet results

Alibaba Group (BABA) released its June quarter 2026 results. Investors are parsing revenue mix and cloud margins for signs of sustainable growth after restructuring; guidance will likely set the tone for China ADRs today.

NetEase (DAO) and sister Youdao (DAO) updated Q2 numbers, adding color on online services and education demand as macro sentiment shifts around Chinese tech names.

AI, data centers & infrastructure

Hudson River Trading (CRWV) will build a next‑gen research platform powered by NVIDIA Vera Rubin on CoreWeave Cloud, underscoring quant demand for hyperscale AI stacks that lift GPU and cloud spend.

Cerebras (CBRS) partnered with Callosum to deliver ultra‑low‑latency agentic inference, a flashpoint in vendor competition for latency‑sensitive AI workloads.

Corning (GLW) extended its reach into AI infrastructure with a long‑term fiber supply agreement with Zayo, signaling durable demand for interconnect as data centers scale GPUs.

Keel Infrastructure (KEEL) voiced support for Pennsylvania’s new GRID standards for responsible data center development, a policy nod that could shape regional siting and power procurement for hyperscalers.

AI deals, product wins and enterprise traction

CXAI (CXAI) secured a $2.5M+ multi‑year contract with a Fortune 100 financial firm, reinforcing recurring revenue expectations for specialized AI vendors.

Conduent (CNDT) teamed with Google Cloud to deliver a GenAI‑powered eDiscovery solution, an enterprise play that could accelerate legal‑tech modernization.

Blend (BLND) released early Autopilot production results, an early example of agentic AI applied to lending operations and potential cost reduction.

Healthcare, biotech and regulatory milestones

Hyperfine (HYPR) announced FDA clearance of its next Optive AI™ software for the Swoop® system, a usability and image‑quality upgrade that can speed clinical adoption.

Rein Therapeutics (RNTX) received FDA Fast Track for LTI‑03 in idiopathic pulmonary fibrosis, lowering development risk and keeping the stock on watch for readouts.

Creative Medical Technology Holdings (CELZ) completed enrollment across its FDA‑cleared ADAPT trial, advancing CELZ‑201 / Olastrocel toward potential RMAT evaluation and Phase 3 planning.

eXoZymes (EXOZ) will report Q2 2026 results and provide a business update at 5 PM ET. For small biotechs, late‑day releases can quickly shift sentiment—watch premarket positioning and any guidance or cash‑burn commentary.

Energy, materials & battery supply

American Battery Technology Company (ABAT) reported its highest‑ever gross profit and a reinstated $57M DOE grant, improving project economics for its battery‑metals roadmap.

CBAK Energy (CBAT) expanded Model 32140 capacity at its Nanjing Phase II facility and advanced digital manufacturing (update), a step toward scaling cell output amid EV and storage demand.

Largo (LGO) secured a US$82.2M debt restructuring, extending maturities to 2030. That breathing room could ease refinancing risk for a key critical‑miner and affect pricing for related battery‑metals peers.

Osisko Gold (ODV) announced an amendment to its US$450M Appian credit facility and satisfaction of technical conditions after completing the Lowhee infill drill program at Cariboo—an operational milestone that de‑risks near‑term project finance.

Defense, aerospace & hardware wins

XTEND (JFB) had its U.S.‑made X‑Strike lethality package accepted into DOW’s Drone Dominance program, an aftermarket and integration revenue opportunity.

AEVEX (AVEX) was awarded a $41M contract to deliver one‑way attack systems. For defense suppliers, visible contract awards help bridge to backlog recognition and cash‑flow visibility.

Maris‑Tech (MTEK) received an additional follow‑on order from an existing governmental intelligence customer (details), validating niche national‑security product demand.

Rocket Lab (RKLB) marked a milestone with the 93rd Electron mission, underscoring cadence that supports backlog monetization.

Crypto, blockchain & digital assets

BTCS (BTCS) reported Q2 gross profit of $1.5M and a 61% gross margin, a read‑through on mining efficiency and power‑cost leverage as BTC swings.

Eightco Holdings (BMNR) disclosed total holdings around $389M, including OpenAI‑related assets and large token positions (report), flagging balance‑sheet exposure to AI and digital‑asset themes.

Notable results & corporate updates

Circle8 Group (ATLN) reported record H1 revenue of $569.7M, up 177% (report), prompting questions about margin sustainability as scale increases.

Ross Stores (ROST) posted strong Q2 sales and earnings, a positive read for off‑price retail demand and inventory digestion heading into back‑to‑school season.

OSI Systems (OSIS) reported fiscal 2026 Q4 and year results and announced an expanded stock repurchase program. Together these moves improve cash‑flow optics and signal management’s confidence in valuation.

Flowers Foods (FLO) reported second quarter results, offering another data point on consumer staples resilience amid mixed discretionary spending.

Corporate moves, governance & listings

Supermicro (SMCI) announced completion of an independent investigation and enhancements to its export compliance program—reducing a regulatory overhang for a key AI‑server supplier.

TROOPS, Inc. (TROO) issued a statement rebutting a short‑seller report and updated on Hong Kong legal proceedings; the rebuttal aims to shore up credibility and could affect short interest.

SU Group Holdings (SUGP) regained compliance with Nasdaq’s minimum bid price requirement (notice), removing a potential delisting risk for shareholders.

Real and RE/MAX Holdings (REAX) announced preliminary results for the election of merger consideration and timing for a share consolidation—important for holders tracking the legal and capital structure ahead of closing.

Coty (COTY) filed its Form 10‑K for fiscal year ended June 30, 2026, a routine but necessary update that provides refreshed financials and risk disclosures ahead of investor meetings.

Small‑cap operational updates

Cosmos Health (COSM) expanded into Saudi Arabia with an exclusive distribution deal and initial purchase order for 126,000 Sky Premium Life units (details), a material commercial entry into the Middle East.

iSpecimen (ISPC) completed a large international cancer research order, shipping samples within three weeks—an operational proof point for sample‑commerce platforms.

NexGel (NXGL) announced a leadership transition and strategic review, prompting possible M&A or restructuring scenarios investors should watch.

Markets & items to watch later today

• Analyst reactions to Alibaba (BABA) cloud guidance and its impact on China ADR sentiment.
• Investor response to AI infrastructure moves from Hudson River Trading, Cerebras and fiber deals like Corning (GLW).
• Credit and project‑finance implications after Largo’s debt extension and Osisko’s credit‑facility amendment.
• Defense contract cadence and backlog visibility following AEVEX (AVEX)’s $41M award.
• Late‑day small‑cap movers, including eXoZymes (EXOZ) as it posts Q2 results and the business update at 5 PM ET.